Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine
biotechnology company, and Nerviano Medical Sciences, S.r.l., a leading
oncology discovery organization, today announced that they have signed a
license agreement that grants Ignyta exclusive global development and
commercialization rights to two new drug development programs, which
Ignyta will refer to as RXDX-103 and RXDX-104.
By Sue Chang, MarketWatch
SAN FRANCISCO (MarketWatch) -- American International Group Inc. is expected to be in the spotlight in Monday's after hours with the insurer slated to release quarterly results.
New Home Company (NEW HOME) (NYSE: NWHM) today announced that
development of The
Cannery , the thoughtfully designed mixed-use neighborhood in Davis,
Calif., is progressing on schedule with the commencement of overall
community grading operations and site improvements.
Binkow & Goldberg LLP announces that it is investigating
potential claims on behalf of investors of Altisource
Portfolio Solutions S.A. (“Altisource” or the “Company”)
(NASDAQ:ASPS) concerning possible violations of federal securities laws.
Shareholder rights law firm Johnson & Weaver, LLP has commenced an
investigation into whether certain officers and directors of ITT
Educational Services, Inc. (NYSE: ESI) violated state or federal laws
regarding its credit practices and statements related to business,
operations and financial prospects.
Proto Labs, Inc. (NYSE: PRLB), a leading online and technology-enabled
quick-turn manufacturer, today announced that it will be presenting at
the 34th Annual Canaccord Genuity Growth Conference on August 14 th
at 3:30 pm Eastern Time.
BALTIMORE , Aug 4, 2014 /PRNewswire/ -- Northrop Grumman Corporation (NYSE: NOC) awarded $50,000 in grants to 167 K-12 schools nationwide to promote education in the science, technology, engineering and mathematics (STEM) disciplines.
Inc. (Nasdaq: IMGN), a biotechnology company that develops novel
anticancer therapeutics using its antibody-drug conjugate (ADC)
technology, today announced that the following presentation by Company
management at an upcoming investor conference will be webcast:
The webcast will be accessible live through the “Investor Information”
section of the Company’s website, www.immunogen.com ;
a replay will be available at the same location for approximately a week.
NEW YORK, NY --
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.